Page last updated: 2024-10-31

mirtazapine and Obesity

mirtazapine has been researched along with Obesity in 4 studies

Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research Excerpts

ExcerptRelevanceReference
" Mirtazapine, a widely used antidepressant, induces adverse metabolic effects such as an increase in body weight."5.12Effect of mirtazapine treatment on body composition and metabolism. ( Deisenhammer, EA; Ebenbichler, CF; Engl, J; Hinterhuber, H; Kramer-Reinstadler, K; Laimer, M; Lechner-Schoner, T; Patsch, JR; Rauchenzauner, M; Strauss, R, 2006)
"Fluoxetine was the reference treatment option in the medication models."1.39Influence of body mass index on the choice of therapy for depression and follow-up care. ( Arterburn, D; Bogart, A; Boudreau, DM; Haneuse, S; Simon, G; Theis, MK; Westbrook, E, 2013)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Puzhko, S1
Schuster, T1
Barnett, TA1
Renoux, C1
Munro, K1
Barber, D1
Bartlett, G1
Boudreau, DM1
Arterburn, D1
Bogart, A1
Haneuse, S1
Theis, MK1
Westbrook, E1
Simon, G1
Fisfalen, ME1
Hsiung, RC1
Laimer, M1
Kramer-Reinstadler, K1
Rauchenzauner, M1
Lechner-Schoner, T1
Strauss, R1
Engl, J1
Deisenhammer, EA1
Hinterhuber, H1
Patsch, JR1
Ebenbichler, CF1

Trials

1 trial available for mirtazapine and Obesity

ArticleYear
Effect of mirtazapine treatment on body composition and metabolism.
    The Journal of clinical psychiatry, 2006, Volume: 67, Issue:3

    Topics: Adipose Tissue; Adult; Antidepressive Agents, Tricyclic; Blood Glucose; Body Composition; Body Fat D

2006

Other Studies

3 other studies available for mirtazapine and Obesity

ArticleYear
Difference in patterns of prescribing antidepressants known for their weight-modulating and cardiovascular side effects for patients with obesity compared to patients with normal weight.
    Journal of affective disorders, 2021, 12-01, Volume: 295

    Topics: Adult; Antidepressive Agents; Canada; Citalopram; Female; Humans; Mirtazapine; Obesity

2021
Influence of body mass index on the choice of therapy for depression and follow-up care.
    Obesity (Silver Spring, Md.), 2013, Volume: 21, Issue:3

    Topics: Adolescent; Adult; Aged; Antidepressive Agents; Body Mass Index; Choice Behavior; Cohort Studies; De

2013
Glucose dysregulation and mirtazapine-induced weight gain.
    The American journal of psychiatry, 2003, Volume: 160, Issue:4

    Topics: Adult; Antidepressive Agents, Tricyclic; Blood Glucose; Body Mass Index; Cocaine-Related Disorders;

2003